Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T-cell/Myeloid Mixed Phenotype Acute Leukemia”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Large-scale testing (Phase 3)UnknownNCT04446130
What this trial is testing

Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Who this might be right for
Induction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more
The First Affiliated Hospital of Soochow University 100
Early research (Phase 1)Active Not RecruitingNCT02159495
What this trial is testing

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more
City of Hope Medical Center 31
Not applicableNot Yet RecruitingNCT07710781
What this trial is testing

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaAcute Lymphoblastic Leukemia+9 more
Ossium Health, Inc. 300
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Large-scale testing (Phase 3)UnknownNCT04257175
What this trial is testing

CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression

Who this might be right for
Acute Myeloid Leukemia
Sheba Medical Center 10
Testing effectiveness (Phase 2)WithdrawnNCT05320380
What this trial is testing

The Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute Leukemia+5 more
Children's Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT07256210
What this trial is testing

Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Early research (Phase 1)WithdrawnNCT05170828
What this trial is testing

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesT-lymphoblastic Lymphoma+4 more
Ossium Health, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07012447
What this trial is testing

Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

Who this might be right for
Early T Acute Lymphoblastic LeukemiaT-Acute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia, T/Myeloid, Nos
yuejun Liu 32
Testing effectiveness (Phase 2)Study completedNCT02793544
What this trial is testing

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma+4 more
Center for International Blood and Marrow Transplant Research 80
Testing effectiveness (Phase 2)Study completedNCT01858740
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+15 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT02220985
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+20 more
Fred Hutchinson Cancer Center 84
Early research (Phase 1)Ended earlyNCT03198234
What this trial is testing

Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders

Who this might be right for
AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Mixed Phenotype Acute Leukemia+3 more
Roncarolo, Maria Grazia, MD 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819396
What this trial is testing

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+11 more
Fred Hutchinson Cancer Center 52
Testing effectiveness (Phase 2)Looking for participantsNCT04195633
What this trial is testing

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more
Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT07216443
What this trial is testing

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMixed Phenotype Acute Leukemia
Orca Biosystems, Inc. 80
Not applicableAvailableNCT07346105
What this trial is testing

Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoid Leukemia+2 more
Orca Biosystems, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT02727803
What this trial is testing

Personalized NK Cell Therapy in CBT

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia+23 more
M.D. Anderson Cancer Center 100
Early research (Phase 1)Looking for participantsNCT06551584
What this trial is testing

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+1 more
Stanford University 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05316701
What this trial is testing

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+4 more
Orca Biosystems, Inc. 187
Next Page